YK
KOBAYASHI Pharmaceutical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Muhi Series | Insect bites, skin inflammation, itching | Approved/Commercial |
| Aneron Series | Gastrointestinal discomfort, indigestion | Approved/Commercial |
| Bathclin Series | Bath additives for relaxation/skin care | Approved/Commercial |
| Clear Clean Series | Acne care, skin cleansing | Approved/Commercial |
| Kobayashi Aerosol Inhaler | Nasal congestion, cold symptoms | Approved/Commercial |
Leadership Team at KOBAYASHI Pharmaceutical
KK
Kazuhisa Kobayashi
Representative Director and President
MK
Masashi Kobayashi
Representative Director and Senior Managing Executive Officer
TK
Takayuki Kobayashi
Director and Senior Managing Executive Officer
HK
Hiroshi Kobayashi
Director
TN
Takeshi Nakatani
Director (Outside Director)
YK
Yoshiko Kita
Director (Outside Director)
SA
Shinji Asada
Director (Outside Director)
YS
Yoshihiko Sano
Standing Corporate Auditor
KT
Kunio Tani
Corporate Auditor (Outside Corporate Auditor)
YO
Yoshimi Ota
Corporate Auditor (Outside Corporate Auditor)